Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-12-08

Clinical Trial Update: iDropper Usability in Glaucoma [Phase 1]

View source ↗

Summary

A Phase 1 usability trial of the iDropper device for open-angle glaucoma has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • iDropper

Snippet

Sponsor: Care Team Solutions | Conditions: Glaucoma, Open-Angle [C11.525.381.407] | Phase 1 | Status: WITHDRAWN